Literature DB >> 7697870

Developmentally regulated glycosylation of dopamine transporter.

A P Patel1, C Cerruti, R A Vaughan, M J Kuhar.   

Abstract

The dopamine transporter (DAT) in rat striatum was examined during postnatal development and aging after photolabeling with [125I]DEEP. The DAT-[125I]DEEP protein complex from adult rats (2 months) appeared as a broad diffuse band in SDS-PAGE gels with average apparent molecular mass of about 80,000 Da as previously found. However, the molecular mass was lower at birth (day 0) and at postnatal ages 4 and 14 days. In aged rats (104 weeks), the molecular mass was slightly higher than that found in young adults (60 days). In binding experiments with [3H]BTCP, there were age-related differences in Kd and Bmax with decreases in both Kd and Bmax found in aged rats. Treatment of photolabeled membranes with neuraminidase caused a reduction in DAT molecular mass, but age-related differences were maintained. Treatment with N-glycanase greatly reduced or eliminated the age-related differences. Several DAT peptide-specific polyclonal antibodies immunoprecipitated DAT-[125I]DEEP protein complex at different developmental ages. Taken together, these results suggest differential glycosylation of rat DAT occurs during postnatal development and aging; the increase is due to increases in the N-linked sugars rather than changes in either sialic acid content or the polypeptide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7697870     DOI: 10.1016/0165-3806(94)90178-3

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  10 in total

Review 1.  The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes.

Authors:  K P Lesch; A Heils; P Riederer
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

Review 2.  Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.

Authors:  Christopher L German; Michelle G Baladi; Lisa M McFadden; Glen R Hanson; Annette E Fleckenstein
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 3.  Model systems for analysis of dopamine transporter function and regulation.

Authors:  Moriah J Hovde; Garret H Larson; Roxanne A Vaughan; James D Foster
Journal:  Neurochem Int       Date:  2018-09-01       Impact factor: 3.921

4.  Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.

Authors:  Q David Walker; Sarah E Morris; Andrew E Arrant; Jacqueline M Nagel; Sarah Parylak; Guiying Zhou; Joseph M Caster; Cynthia M Kuhn
Journal:  J Pharmacol Exp Ther       Date:  2010-07-06       Impact factor: 4.030

5.  Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter.

Authors:  S R Sesack; V A Hawrylak; C Matus; M A Guido; A I Levey
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

6.  Glutamate transporter protein subtypes are expressed differentially during rat CNS development.

Authors:  A Furuta; J D Rothstein; L J Martin
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

7.  Cocaine increases stimulated dopamine release more in periadolescent than adult rats.

Authors:  Q David Walker; Cynthia M Kuhn
Journal:  Neurotoxicol Teratol       Date:  2008-04-22       Impact factor: 3.763

8.  Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity.

Authors:  Trent J Volz; Sarah J Farnsworth; Shane D Rowley; Glen R Hanson; Annette E Fleckenstein
Journal:  Synapse       Date:  2009-02       Impact factor: 2.562

9.  A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake.

Authors:  Beryl Luk; Mohinuddin Mohammed; Fang Liu; Frank J S Lee
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

Review 10.  Transgenic mouse models for ADHD.

Authors:  Damiana Leo; Raul R Gainetdinov
Journal:  Cell Tissue Res       Date:  2013-05-17       Impact factor: 5.249

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.